Evaluating the Utility of the C-Reactive Protein to Albumin Ratio in Retinal Vein Occlusion Assessment - Report - MDSpire

Evaluating the Utility of the C-Reactive Protein to Albumin Ratio in Retinal Vein Occlusion Assessment

  • By

  • Esra Vural

  • Leyla Hazar

  • November 25, 2025

  • 0 min

Share

Clinical Report: Evaluating the Utility of the C-Reactive Protein to Albumin Ratio in Retinal Vein Occlusion Assessment

Overview

Revise to specify which traditional markers are being compared to the CRP/albumin ratio.

Background

Retinal vein occlusion (RVO) is a significant cause of vision loss and is associated with various systemic inflammatory conditions. Understanding the inflammatory markers related to RVO can aid in better risk stratification and management of affected patients. The CRP/albumin ratio has been proposed as a potential prognostic tool, warranting further investigation in the context of RVO.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

Verify and ensure all findings are accurately represented and supported by the source.

Clinical Implications

Clinicians should consider the CRP/albumin ratio as a potential marker for assessing inflammation in RVO patients. This could enhance risk assessment and guide treatment strategies, particularly in managing systemic vascular risks and co-morbid conditions.

Conclusion

Highlight the types of studies needed for further validation of the CRP/albumin ratio.

References

  1. Retinal Physician, 2020 -- Disorganization of the Retinal Inner Layers as a Prognostic Biomarker
  2. Retinal Physician, 2017 -- Halting and Reversing DR Progression With Anti-VEGF: Clinical and Economic Relevance
  3. Retinal Physician, 2015 -- How RAP and PCV Can Affect the Management of AMD
  4. Ophthalmology Management, 2013 -- Retina Roundup
  5. Retinal Vein Occlusions Preferred Practice Pattern® - PubMed, 2023
  6. Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion - PubMed, 2023
  7. Systemic Inflammation in Retinal Vein Occlusion and Its Role in Clinical Outcomes of Secondary Macular Edema
  8. Retinal Vein Occlusions Preferred Practice Pattern® - PubMed
  9. Effectiveness and safety of anti-vascular endothelial growth factor therapies for macular edema in retinal vein occlusion: A systematic review and network meta-analysis of randomized controlled trials - PubMed
  10. Systemic Inflammation in Retinal Vein Occlusion and Its Role in Clinical Outcomes of Secondary Macular Edema

Original Source(s)

Evaluating the Utility of the C-Reactive Protein to Albumin Ratio in Retinal Vein Occlusion Assessment

  • by Esra Vural, Leyla Hazar

  • November 25, 2025

Related Content

Diabetic Retinal Disease Rates Narrow by Diabetes Type

US claims data showed rising prevalence of diabetic retinal disease in type 1 and type 2 diabetes, while incidence declined in type 1 diabetes and moved closer to type 2 rates by 2022.

AI Screening for Diabetic Retinopathy

Scaling Diabetic Eye Care in Vietnam

Orbis and Roche launch major diabetic eye care initiative in the country

  • March 17, 2026

  • 2 min